AGE - AgeX Therapeutics Inc
Previous close
11.1
0 0%
Share volume: 21,904
Last Updated: Tue 26 Mar 2024 05:00:00 AM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$11.10
0.00
0.00%
Summary score
8%
Profitability
11%
Dept financing
26%
Liquidity
3%
Performance
0%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Sep-2019 - 30-Sep-2023
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
42.39%
Return on assets
-55.17%
Return on sales
-10410.26%
Return on invested capital
-142.88%
Total debt ratio
352.86%
Debt ratio change over timeo
8.84%
Current Ratio
0.34%
Quick Ratio
0.26%
Cash Position Ratio
0.14%
Short-term ratios 30-Sep-2022 - 30-Sep-2023
The data are presented for the financials results of the quarters of the last year.
Return on equity
-4.98%
Return on assets
-26.73%
Return on sales
-17087.99%
Return on invested capital
2%
Total debt ratio
300.37%
Debt ratio change over timeo
7%
Current Ratio
0.18%
Quick Ratio
0.18%
Cash Position Ratio
0.05%
Last quarter ratios 30-Sep-2023
The data are presented for the financials results of the last quarter.
Return on equity
-64.13%
Return on assets
-19.3%
Return on sales
-3516.42%
Return on invested capital
-68.67%
Total debt ratio
31.02%
Debt ratio change over time
-0.69%
Current Ratio
0.36%
Quick Ratio
0.36%
Cash Position Ratio
0.12%
Performance ratios (change over 4 years) 30-Sep-2019 - 30-Sep-2023
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-50.13%
Return on assets
-226.84%
Return on sales
-29479.33%
Return on invested capital
13.92%
Total debt ratio
883.96%
Debt ratio change over time
8.84%
Current Ratio
-0.5%
Quick Ratio
-0.39%
Cash Position Ratio
-0.82%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | AGE | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 42.39% | 7.58% | 36.15% | 7.75% |
| Return on assets | -55.17% | 2.95% | 3.44% | 5.85% |
| Return on sales | -10410.26% | 30.63% | 35.3% | 41.32% |
| Return on invested capital | -142.88% | 3.7% | 6.05% | 20.44% |
| Profitability | 25% | 40% | 65% | 80% |
| Total debt ratio | 352.86% | 92.36% | 89.3% | 27.07% |
| Debt ratio change over time | 8.84% | 292.67% | 15.45% | 1.02% |
| Dept financing | 26% | 32% | 8% | 2% |
| Current Ratio | 0.18% | 0.94% | 2.55% | 5.29% |
| Quick Ratio | 0.18% | 0.82% | 2.23% | 4.52% |
| Cash Position Ratio | 0.05% | 0.3% | 1.72% | 2.75% |
| Liquididy | 6% | 22% | 35% | 75% |
| Short-term ratios | AGE | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -4.98% | 11.57% | 35.05% | 4.21% |
| Return on assets | -26.73% | 2.86% | 2.7% | 3.6% |
| Return on sales | -17087.99% | 27.99% | 31.88% | 33.53% |
| Return on invested capital | 2% | 2.16% | 6.93% | 9.79% |
| Profitability | 5% | 54% | 85% | 78% |
| Total debt ratio | 300.37% | 89.83% | 93.1% | 22.12% |
| Debt ratio change over time | 7% | 102.83% | 13.09% | 1.3% |
| Dept financing | 27% | 32% | 11% | 2% |
| Current Ratio | 0.18% | 0.94% | 2.55% | 5.29% |
| Quick Ratio | 0.18% | 0.82% | 2.23% | 4.52% |
| Cash Position Ratio | 0.05% | 0.3% | 1.72% | 2.75% |
| Liquididy | 2% | 12% | 40% | 75% |